<table id="L37f6b302-47c6-4d05-a5ea-f746aa1aca63" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Predicted Pharmacokinetic Parameters of Amphotericin B after Administration of Multiple Doses of 1 mg/kg Amphotericin B Deoxycholate [a]</caption>
<colgroup>
<col width="75%"></col>
<col width="24%"></col>
</colgroup>
<thead>
<tr><td>Mean Pharmacokinetic Parameter [b]</td><td align="center">Values</td></tr>
</thead>
<tfoot>
<tr><td colspan="2">[a] Data obtained using population modeling in 15 patients in whom amphotericin B deoxycholate was administered for treatment of aspergillus infection or empiric therapy. The modeling assumes amphotericin B pharmacokinetics after administration of amphotericin B deoxycholate are best described by a 2-compartment model. Infusion rate = 0.25 mg/kg/hour.</td></tr>
<tr><td colspan="2">[b]  Definitions: Vss - Volume of distribution at steady state, CLt - Total plasma clearance, Cmax - Maximum plasma concentration achieved at the end of an infusion, AUCss - Area under the plasma concentration time curve at steady-state.</td></tr>
</tfoot>
<tbody>
<tr><td>Vss (L/kg) </td><td align="center">1.1</td></tr>
<tr><td>CLt (L/h/kg) </td><td align="center">0.028</td></tr>
<tr><td>Distribution Half-Life (minutes) </td><td align="center">38</td></tr>
<tr><td>Elimination Half-Life (hours) </td><td align="center">39</td></tr>
<tr><td>Cmax (μg/mL) </td><td align="center">2.9</td></tr>
<tr><td>AUCss (μg/mL•h)</td><td align="center">36</td></tr>
</tbody>
</table>